Cellular therapy

September 23, 2022

Binaytara Foundation September Conferences

The Binaytara Foundation hosted two conferences in September 2022

Conference 2023/Conferences

Binaytara Foundation Hosted Seattle Cellular Therapy Summit

Hematologists & Oncologists from Across Country Met to Discuss Latest Updates in Care On August 4-5, 2023, the Binaytara Foundation held the Seattle Cellular Therapy Summit. This annual conference gathers leading experts to present the latest treatments and practice-changing

August 8, 2023

FDA Approves Talquetamab-Tgvs For Adults with Relapsed Or Refractory Multiple Myeloma Patients with at least Four Prior Lines of Therapy

New Approvals/New Drug Applications

By Dr. Anish Shah Bronx Lebanon Hospital On August 9, 2023, the U.S. Food and Drug Administration approved talquetamab-tgvs (Talvey, Janssen Biotech, Inc.)

New Approvals/New Drug Applications

FDA Approves Talquetamab-Tgvs For Adults with Relapsed Or Refractory Multiple Myeloma Patients with at least Four Prior Lines of Therapy

By Dr. Anish Shah Bronx Lebanon Hospital On August 9, 2023, the U.S. Food and Drug Administration approved talquetamab-tgvs (Talvey, Janssen Biotech, Inc.) for adults with multiple myeloma with relapsed or